13 Best Healthcare Dividend Stocks to Invest in

6. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders: 91

Merck & Co., Inc. (NYSE:MRK) is an American multinational pharmaceutical company, headquartered in New Jersey. The company’s substantial investment in research and development, along with its strategic emphasis on cardiovascular and rare diseases, reinforces confidence in its long-term revenue growth. In addition, the healthcare sector’s resilience during economic downturns enhances Merck’s attractiveness as an investment, as the demand for essential medications remains stable regardless of market conditions.

Merck & Co., Inc. (NYSE:MRK) reported strong financial performance, with revenue increasing 7% year-over-year to $15.6 billion. The company has strengthened its presence in specialty pharmaceuticals and oncology, with Keytruda remaining a cornerstone of its cancer treatment portfolio and a key contributor to revenue growth. Merck’s solid market position has enabled it to maintain consistent cash flow, supporting its commitment to shareholder returns.

For the full year, Keytruda sales jumped 18% from the previous year, reaching $29.5 billion. The drug is expected to generate more than $35 billion in revenue by 2028 before its patent expires, further cementing Merck’s leadership in the immunotherapy market.

Merck & Co., Inc. (NYSE:MRK)’s quarterly dividend comes in at $0.81 per share and has a dividend yield of 3.44%. It is one of the best dividend stocks on our list with 14 consecutive years of dividend growth under its belt.